PROCEPT BioRobotics (PRCT) Research & Development (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Research & Development data on file, last reported at $21.5 million in Q1 2026.

• Research & Development for Q1 2026 came in at $21.5 million, up 30.87% year-over-year; the trailing twelve-month figure through Mar 2026 was $76.3 million (up 16.34% YoY), and the FY2025 annual result was $71.3 million, up 14.41% from the prior year.
• Research & Development improved to $21.5 million in Q1 2026 per PRCT's latest filing, from $19.1 million in the prior quarter.
• Over five years, Research & Development peaked at $21.5 million in Q1 2026 and troughed at $5.0 million in Q1 2022.
• A 5-year average of $13.7 million and a median of $14.5 million in 2023 frame the typical range for Research & Development.
• The sharpest annual moves came in 2023 and 2025: Research & Development surged 114.27% in 2023, then grew 0.75% in 2025.
• A 5-year view of Research & Development shows it stood at $9.7 million in 2022, then surged by 49.72% to $14.5 million in 2023, then climbed by 3.93% to $15.1 million in 2024, then grew by 26.48% to $19.1 million in 2025, then gained by 12.64% to $21.5 million in 2026.
• Business Quant data shows PRCT's Research & Development at $21.5 million in Q1 2026, $19.1 million in Q4 2025, and $18.2 million in Q3 2025.